We are live on ! Find out more
USNA icon

Usana Health Sciences

123 hedge funds and large institutions have $528M invested in Usana Health Sciences in 2014 Q2 according to their latest regulatory filings, with 11 funds opening new positions, 32 increasing their positions, 58 reducing their positions, and 33 closing their positions.

New
Increased
Maintained
Reduced
Closed

0% more funds holding in top 10

Funds holding in top 10: 11 (0)

9% less capital invested

Capital invested by funds: $581M → $528M (-$53M)

13.84% less ownership

Funds ownership: 110.97%97.13% (-14%)

15% less funds holding

Funds holding: 145123 (-22)

45% less repeat investments, than reductions

Existing positions increased: 32 | Existing positions reduced: 58

67% less first-time investments, than exits

New positions opened: 11 | Existing positions closed: 33

Holders
123
Holders Change
-22
Holders Change %
-15.17%
% of All Funds
3.54%
Holding in Top 10
1
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
0.03%
New
11
Increased
32
Reduced
58
Closed
33
Calls
Puts
Net Calls
Net Calls Change
Name Holding Trade Value Shares
Change
Change in
Stake
Fidelity Investments
1
Fidelity Investments
Massachusetts
$127M -$4.38K -118 -0%
Renaissance Technologies
2
Renaissance Technologies
New York
$52.8M +$1.59M +42,834 +3%
Vanguard Group
3
Vanguard Group
Pennsylvania
$34.5M -$4.64M -125,036 -12%
Dimensional Fund Advisors
4
Dimensional Fund Advisors
Texas
$27.6M +$8.31K +224 +0%
Schroder Investment Management Group
5
Schroder Investment Management Group
United Kingdom
$27.3M -$186K -5,000 -0.7%
LSV Asset Management
6
LSV Asset Management
Illinois
$26.8M +$75.5K +2,034 +0.3%
BIT
7
BlackRock Institutional Trust
California
$17.2M -$3.09M -83,236 -16%
Norges Bank
8
Norges Bank
Norway
$11.4M +$5.44M +146,512 +100%
BFA
9
BlackRock Fund Advisors
California
$11.2M -$600K -16,160 -5%
WA
10
Wasatch Advisors
Utah
$10.4M +$2.03M +54,592 +26%
Arrowstreet Capital
11
Arrowstreet Capital
Massachusetts
$10.1M -$1.43M -38,484 -13%
State Street
12
State Street
Massachusetts
$7.98M -$268K -7,224 -3%
Northern Trust
13
Northern Trust
Illinois
$7.1M -$3.52M -94,796 -34%
Deutsche Bank
14
Deutsche Bank
Germany
$6.93M -$1.1M -29,762 -14%
JP Morgan Chase
15
JP Morgan Chase
New York
$6.47M -$3.72M -100,196 -38%
Morgan Stanley
16
Morgan Stanley
New York
$6.07M -$3M -80,882 -34%
American Century Companies
17
American Century Companies
Missouri
$5.78M +$8.54K +230 +0.2%
Bank of New York Mellon
18
Bank of New York Mellon
New York
$5.66M -$8.61M -231,920 -62%
Goldman Sachs
19
Goldman Sachs
New York
$5.6M -$1.25M -33,590 -19%
QBFM
20
QS Batterymarch Financial Management
New York
$4.83M -$331K -8,920 -7%
BGIM
21
Brandywine Global Investment Management
Pennsylvania
$4.17M -$371K -10,000 -9%
ETM
22
Euclidean Technologies Management
Washington
$4.07M -$341K -9,200 -8%
Barclays
23
Barclays
United Kingdom
$3.85M +$3.24M +87,218 +758%
D.E. Shaw & Co
24
D.E. Shaw & Co
New York
$3.74M -$745K -20,072 -17%
ARC
25
Absolute Return Capital
Massachusetts
$3.73M -$1.35M -36,360 -28%

USNA Hedge Fund Activity: Q2 2014 in Review

123 of the 3,479 institutional investors tracked by Wall St. Rank reported a position in Usana Health Sciences (USNA) for Q2 2014, worth a combined $528M — down 9.1% from $581M a quarter earlier.

Sellers outnumbered buyers: 33 funds closed out of USNA and 11 opened new positions — a net loss of 22 holders — while 58 trimmed existing stakes and 32 added.

The largest buyer was Norges Bank, adding an estimated $5.44M. The largest seller was Bank of New York Mellon, cutting an estimated $8.61M.

  • 123 institutional investors held Usana Health Sciences (USNA) as of Q2 2014, down from 145 in Q1 2014.
  • Funds reported $528M of Usana Health Sciences stock for Q2 2014, down 9.1% quarter-over-quarter.
  • 11 funds opened new Usana Health Sciences positions in Q2 2014 and 33 closed out, a net change of -22 holders.
  • The largest Usana Health Sciences buyer in Q2 2014 was Norges Bank, an estimated $5.44M added.
  • The largest Usana Health Sciences seller in Q2 2014 was Bank of New York Mellon, an estimated $8.61M sold.

Based on aggregated 13F filings for Q2 2014.